Aishwarya Muddebihal

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Particulate Matter

Binding Protein

Artificial Intelligence

Top Venues

Expert review of endocrinology & metabolism

Expert review of clinical pharmacology

Clinical and experimental dermatology

Contact dermatitis

This page only lists publications with an associated author ORCID identifier.

Publications

Kabir Sardana, Aishwarya Muddebihal, Manu Sehrawat, Prekshi Bansal, Ananta Khurana
An updated clinico-investigative approach to diagnosis of cutaneous hyperandrogenism in relation to adult female acne, female pattern alopecia & hirsutism a primer for dermatologists. Expert review of endocrinology & metabolism 19 (2) (2024)
Kabir Sardana, Aishwarya Muddebihal, Manu Sehrawat, Prekshi Bansal, Ananta Khurana
An updated clinico-investigative approach to diagnosis of cutaneous hyperandrogenism in relation to adult female acne, female pattern alopecia & hirsutism a primer for dermatologists. Expert review of endocrinology & metabolism 19 (2) (2024)
Shyam Bhanushankar Verma, Nandakumar Gopinath, Resham Vasani, Aishwarya Muddebihal, Kabir Sardana
Erythema annulare centrifugum trailing behind dermatophytosis - Causation or association. Clinical and experimental dermatology (2023)
Kabir Sardana, Aishwarya Muddebihal, Ananta Khurana
JAK inhibitors in vitiligo: what they hit and what they miss - an immunopathogenesis based exposition of existing evidence. Expert review of clinical pharmacology (2023)
Aishwarya Muddebihal, Ananta Khurana, Kabir Sardana
JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review. Expert review of clinical pharmacology (2023)
Kabir Sardana, Aishwarya Muddebihal, Manu Sehrawat, Prekshi Bansal, Ananta Khurana
An updated clinico-investigative approach to diagnosis of cutaneous hyperandrogenism in relation to adult female acne, female pattern alopecia & hirsutism a primer for dermatologists. Expert review of endocrinology & metabolism (2023)
Aishwarya Muddebihal, Kabir Sardana, Surabhi Sinha, Dharmesh Kumar
Tofacitinib in refractory Parthenium-induced airborne allergic contact dermatitis. Contact dermatitis (2022)